The primary study endpoint is the quality of life of the individual patient at the end of one year. Quality of life is measured using standardized self-report instruments administered preoperatively and in annual follow-up.
Cancer occurrence, adverse effects, imaging findings, and survival are all secondary outcomes that we will be following.
18 Years to 70 Years (Adult, Senior)
November 8, 2007
December 2, 2016
Georgetown University Hospital Washington, District of Columbia, United States
† Study has passed its completion date and status has not been verified in more than two years.